Identification and Characterization of USP7 Targets in Cancer Cells

Anna Georges1, Edyta Marcon2, Jack Greenblatt1,2

  • 1Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Scientific Reports
|October 28, 2018
PubMed

Insights

The ubiquitin specific protease, USP7, regulates cancer pathways by interacting with proteins. This study identifies DDX24 and DHX40 as new USP7 targets, revealing novel binding mechanisms and stabilization roles.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The ubiquitin specific protease, USP7, is crucial in cancer by regulating protein stability and cellular pathways.
  • USP7's interactions with target proteins are key to its function, but a comprehensive profile in cancer cells is needed.

Purpose of the Study:

  • To identify novel USP7 binding targets in gastric carcinoma cells.
  • To elucidate the binding mechanisms and functional regulation of USP7 interactions.

Main Methods:

  • Affinity purification coupled with mass spectrometry was used to identify USP7 binding partners.
  • USP7 binding pocket mutants and catalytic activity modulation were employed to study interaction mechanisms and protein stabilization.

Main Results:

  • USP7 interactions with USP11, PPM1G, and TRIP12 were confirmed; novel interactions with DDX24 and DHX40 (DEAD/DEAH-box RNA helicases) were identified.
  • USP11, PPM1G, TRIP12, and DDX24 bind via USP7's TRAF domain pocket, while DHX40 binds via the Ubl2 domain pocket.
  • USP7's catalytic activity stabilizes DDX24, DHX40, and TRIP12, but not USP11 or PPM1G.

Conclusions:

  • This study defines USP7 interaction mechanisms and identifies DDX24 and DHX40 as novel, catalytically regulated targets.
  • Understanding these interactions provides new insights into USP7's role in cancer biology and potential therapeutic strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Methods of Classification and Identification01:28

Methods of Classification and Identification

Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
1.2K